The pharmaceutical industry's pursuit of effective treatments for cardiovascular diseases often hinges on the precise synthesis of complex molecules. Atorvastatin Calcium, a widely prescribed statin, is one such medication where the quality of its intermediates directly influences the final product. Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate, identified by its CAS number 141942-85-0, is a critical atorvastatin calcium intermediate, and its purity and consistency are of utmost importance. NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated provider of this essential chemical building block, ensuring manufacturers have access to reliable materials.

The synthesis pathway for Atorvastatin Calcium involves multiple steps, each requiring intermediates that meet stringent specifications. Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate plays a pivotal role in constructing the core structure of Atorvastatin. Its specific molecular configuration and high assay (≥98.0%) are vital for achieving the desired stereochemistry and purity in the final drug product. For companies engaged in the production of cholesterol-lowering drugs, securing a dependable supply of this key atorvastatin intermediate is non-negotiable. NINGBO INNO PHARMCHEM CO.,LTD. is committed to being that dependable supplier.

When seeking to buy Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate, businesses often look for suppliers who understand the nuances of pharmaceutical manufacturing. The physical properties of the compound, such as its liquid form, are advantageous for process integration. Moreover, its role as an intermediate in the synthesis of atorvastatin intermediate means that its quality directly impacts the overall quality and safety of the Atorvastatin Calcium medication. NINGBO INNO PHARMCHEM CO.,LTD. prioritizes these aspects, offering a product that meets global pharmaceutical standards.

NINGBO INNO PHARMCHEM CO.,LTD. is proud to contribute to the healthcare sector by supplying high-quality pharmaceutical intermediates. Our expertise in the synthesis and supply of compounds like Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate enables our clients to focus on their core business of developing and manufacturing life-saving drugs. We encourage pharmaceutical companies and research institutions to contact us for their needs regarding this critical atorvastatin calcium intermediate and explore partnership opportunities.